Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-15 Tax Withholding |
2022-03-17 5:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President of R&D |
2,607 | $15.79 | 120,708 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 8:51 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
5,053 | $13.35 | 123,315 (Direct) |
View |
| 2021-03-15 Tax Withholding |
2021-03-17 7:27 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
1,354 | $27.73 | 128,368 (Direct) |
View |
| 2021-02-15 Tax Withholding |
2021-02-19 8:10 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
4,848 | $28.97 | 129,722 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 9:16 pm |
N/A 2031-02-01 |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
63,545 | $0 | 175,495 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 8:31 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
7,382 | $25.14 | 111,950 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 8:31 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D |
17,500 | $0 | 111,950 (Direct) |
View |